Company logo

ATHA - Athira Pharma, Inc.

NASDAQ -> Healthcare -> Biotechnology
Bothell, United States

ATHA price evolution
ATHA
(in millions $) 31 Mar 2022 31 Dec 2021 30 Sep 2021 30 Jun 2021
Current assets
Cash $118.02 $110.54 $107.33 $131.7
Short term investments $145.72 $143.22 $128.45 $153.24
Net receivables $2.23 $2.34 $2.08 $2.59
Inventory
Total current assets $269.15 $260.8 $238.99 $290.5
Long term investments $37.64 $65.94 $103.65 $64.94
Property, plant & equipment $5.77 $5.22 $4.57 $4.46
Goodwill & intangible assets
Total noncurrent assets $43.85 $71.21 $108.34 $69.63
Total investments $183.36 $209.16 $232.1 $218.18
Total assets $313 $332.01 $347.33 $360.12
Current liabilities
Accounts payable $1.43 $0.57 $0.96 $1.17
Deferred revenue
Short long term debt $0.3 $0.29 $0.28 $0.26
Total current liabilities $9.47 $9.29 $9.39 $7.63
Long term debt $1.55 $1.63 $1.71 $1.78
Total noncurrent liabilities $1.55 $1.63 $1.71 $1.78
Total debt $1.85 $1.92 $1.99 $2.04
Total liabilities $11.03 $10.92 $11.09 $9.41
Shareholders' equity
Retained earnings -$116.88 -$95.89 -$79.56 -$63.88
Other shareholder equity -$1.46 -$0.39 $0 $0.04
Total shareholder equity $301.98 $321.08 $336.24 $350.71
(in millions $) 31 Dec 2021 31 Dec 2020 31 Dec 2019 30 Jan 2019
Current assets
Cash $110.54 $60.63 $2.06 $3.32
Short term investments $143.22 $124.06 $0.01
Net receivables $2.34 $1.3
Inventory
Total current assets $260.8 $192.34 $2.16 $4.9
Long term investments $65.94 $83.51 $0.03
Property, plant & equipment $5.22 $3.58
Goodwill & intangible assets
Total noncurrent assets $71.21 $87.23 $0.03 $0.04
Total investments $209.16 $207.57 $0.04
Total assets $332.01 $279.56 $2.19 $4.93
Current liabilities
Accounts payable $0.57 $1.16 $0.42 $0.12
Deferred revenue
Short long term debt $0.29 $0.12
Total current liabilities $9.29 $4.41 $1.27 $0.57
Long term debt $1.63 $0.88 $1.55 $0.7
Total noncurrent liabilities $1.63 $0.88 $3.59 $2.2
Total debt $1.92 $1 $1.55
Total liabilities $10.92 $5.28 $4.86 $2.77
Shareholders' equity
Retained earnings -$95.89 -$41.04 -$21.09 -$15.93
Other shareholder equity -$0.39 $0.03 $17.05 $17.05
Total shareholder equity $321.08 $274.28 -$19.72
(in millions $) 31 Mar 2022 31 Dec 2021 30 Sep 2021 30 Jun 2021
Revenue
Total revenue
Cost of revenue
Gross Profit
Operating activities
Research & development $14.46 $12.62 $10.71 $12.02
Selling, general & administrative $8.93 $6.16 $7.12 $4.61
Total operating expenses $23.39 $18.78 $17.83 $16.64
Operating income -$23.39 -$18.78 -$17.83 -$16.64
Income from continuing operations
EBIT -$20.98 -$16.34 -$15.67 -$13.97
Income tax expense
Interest expense
Net income
Net income -$20.98 -$16.34 -$15.67 -$13.97
Income (for common shares) -$20.98 -$16.34 -$15.67 -$13.97
(in millions $) 31 Dec 2021 31 Dec 2020 31 Dec 2019 30 Jan 2019
Revenue
Total revenue
Cost of revenue
Gross Profit
Operating activities
Research & development $42.79 $13.29 $3.79
Selling, general & administrative $21.23 $6.71 $1.66
Total operating expenses $64.02 $20 $5.45 $5.01
Operating income -$64.02 -$20 -$5.45 -$5.01
Income from continuing operations
EBIT -$54.85 -$19.95 -$5.16
Income tax expense
Interest expense
Net income
Net income -$54.85 -$19.95 -$5.16 -$5.1
Income (for common shares) -$54.85 -$19.95 -$5.16
(in millions $) 31 Mar 2022 31 Dec 2021 30 Sep 2021 30 Jun 2021
Net income -$20.98 -$16.34 -$15.67 -$13.97
Operating activities
Depreciation $0.2 $0.13 $0.12 $0.12
Business acquisitions & disposals
Stock-based compensation $2.73 $1.44 $1.1 $1.11
Total cash flows from operations -$16.57 -$18.18 -$10.3 -$7.32
Investing activities
Capital expenditures -$0.74 -$1.03 -$0.13 -$0.11
Investments $24.59 $22.4 -$14.07 $11.57
Total cash flows from investing $23.85 $21.37 -$14.2 $11.46
Financing activities
Dividends paid
Sale and purchase of stock $0.21 $0.01 $0.13 -$0.26
Net borrowings
Total cash flows from financing $0.21 $0.01 $0.13 -$0.26
Effect of exchange rate
Change in cash and equivalents $7.48 $3.21 -$24.37 $3.88
(in millions $) 31 Dec 2021 31 Dec 2020 31 Dec 2019 30 Jan 2019
Net income -$54.85 -$19.95 -$5.16 -$5.1
Operating activities
Depreciation $0.48
Business acquisitions & disposals $0.04 $0.01
Stock-based compensation $4.62 $0.63 $0.25
Total cash flows from operations -$43.1 -$24.11 -$3.71 -$4.48
Investing activities
Capital expenditures -$1.57 -$2.32
Investments -$2.51 -$207.78 $1.5
Total cash flows from investing -$4.08 -$210.07 $1.51 $2.01
Financing activities
Dividends paid
Sale and purchase of stock $97.09 $209.16 $0.07
Net borrowings $1.66 $0.87
Total cash flows from financing $97.09 $292.75 $0.95 $1.46
Effect of exchange rate
Change in cash and equivalents $49.91 $58.57 -$1.26 -$1.01
Fundamentals
Market cap $121.14M
Enterprise value $4.97M
Shares outstanding 37.62M
Revenue $0.00
EBITDA -$66.40M
EBIT -$66.97M
Net Income -$66.97M
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio -1.81
EV/Sales N/A
EV/EBITDA -0.07
EV/EBIT -0.07
P/S ratio N/A
P/B ratio 0.40
Book/Share 8.07
Cash/Share 3.14
EPS -$1.78
ROA -19.81%
ROE -20.45%
Debt/Equity 0.03
Net debt/EBITDA 1.61
Current ratio 28.42
Quick ratio 28.42